- Recce Pharmaceuticals (RCE) has begun the process to dual list on the Frankfurt Stock Exchange (FSE)
- The company has appointed Deutsche Gesellschaft Für Wertpapieranalyse (DGWA) as its investor and corporate relations advisor in Europe
- DGWA will engage prospective investors and drive awareness of Recce's productsDual listing on the FSE will give Recce exposure to multiple retail and institutional investors in the European Union
- The company will keep the market updated as the listing progresses Shares in Recce are steady on the market and are trading at $1.05 per share
Read the full article on The Market Herald here.
- Forums
- ASX - By Stock
- RCE
- Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.0¢ |
Change
0.010(2.33%) |
Mkt cap ! $89.62M |
Open | High | Low | Value | Volume |
43.0¢ | 44.0¢ | 43.0¢ | $24.01K | 55.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 72121 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 29087 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 72121 | 0.430 |
3 | 77224 | 0.425 |
2 | 150903 | 0.420 |
3 | 127049 | 0.415 |
7 | 153894 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 29087 | 2 |
0.460 | 20330 | 2 |
0.465 | 23931 | 1 |
0.470 | 10000 | 1 |
0.495 | 2020 | 1 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
44.0¢ |
  |
Change
0.010 ( 2.33 %) |
|||
Open | High | Low | Volume | ||
43.5¢ | 44.0¢ | 43.0¢ | 7544 | ||
Last updated 15.59pm 28/03/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online